RXO, Inc. reported $6.09B of revenue over the trailing twelve months, +9.5% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.09B (to Q2 2026). Net income: −$105M, trailing twelve months to Q2 2026. Free cash flow: −$76M, trailing twelve months to Q2 2026. Operating margin: −1.3%, trailing twelve months to Q2 2026.

RXORXO, Inc.

Industrials

$29.06+80% 1Y

$29.06

$10.4852 weeks$29.30

RXO as reported

RXO, Inc. reported $6.09B of revenue over the trailing twelve months, +9.5% on the year before. 10 reported series are charted on this page, each one as filed.

$6.09B

Revenue, trailing twelve months · to Q2 2026 · +9.5% against the twelve months before

Net income: −$105M
Net income · −66% year on year · trailing twelve months to Q2 2026
Free cash flow: −$76M
Free cash flow · +69% year on year · trailing twelve months to Q2 2026
Operating margin: −1.3%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for RXO, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.09B	+9.5%	Q2 2026
Net income	−$105M	−66%	Q2 2026
EPS	−$0.61	−70%	Q2 2026
Gross margin	18%	n/a	Q2 2026
Operating margin	−1.3%	n/a	Q2 2026
Net margin	−1.8%	n/a	Q2 2026
ROE	−6.4%	n/a	Q2 2026
ROA	−2.9%	n/a	Q2 2026
ROIC	−3.0%	n/a	Q2 2026
Free cash flow	−$76M	+69%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.